Patel, Whole Time Director ofthe Company retire by rotation at the ensuing AGM and they being eligible offer themselves for re-appointment. The Board recommends their reappointment. Necessary ...

EyePoint Pharmaceuticals, Inc. has appointed Dr. Reginald J. Sanders, a prominent ophthalmologist and former president of the American Society of Retina Specialists, to its Board of Directors.

As per the agreement, Sauer Nunes is entitled to designate a member to the Board of Directors of NRx Pharmaceuticals. The management is currently evaluating nominees designated by Sauer Nunes for ...

“Renewcast is honored to welcome Lincoln Bleveans to our Board of Directors,” said Fabio Nicolò, CEO of Renewcast.“His visionary leadership and deep energy industry experience align ...

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS), a $1.78 billion market cap company specializing in biological products, announced ...

Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, ...

NRx Pharmaceuticals, Inc. (NASDAQ ... announced the immediate resignation of Janet Rehnquist from its Board of Directors on January 7, 2025. According to the company's recent SEC filing, the ...

BioXcel Therapeutics, Inc. (NASDAQ:BTAI), a pharmaceutical company specializing in drug development with a current market ...

Enzon Pharmaceuticals has expanded its Board of Directors to four members and appointed Stephen T. Wills as a new director. Wills brings extensive experience from his roles at various ...

EyePoint Pharmaceuticals announced the appointment of Dr. Reginald J. Sanders, a renowned retina specialist and leader in ophthalmology, to its Board of Directors. This strategic addition is ...